Location History:
- Helsingor, DK (2006)
- Helsingoer, DK (2013 - 2014)
- Ringsted, DK (2021)
Company Filing History:
Years Active: 2006-2021
Title: Innovator Spotlight: Thomas Aaskov Pedersen
Introduction
Thomas Aaskov Pedersen, an accomplished inventor based in Ringsted, Denmark, has made significant contributions to the field of medicine through his innovative patents. With a total of four patents to his name, Pedersen is notably recognized for his work in advancing medical delivery systems and insulin formulations.
Latest Patents
Among his latest inventions is a bioassay for insulin formulations, which focuses on quantifying phosphorylated Akt. This invention enhances the accuracy of potency determination by mitigating the interference caused by excipients in oral and liquid formulations containing low affinity insulin peptides. Another of his significant contributions is a medical delivery system that features a unique coding mechanism. This system ensures that only predetermined containers can be securely fastened to designated dosing assemblies, optimizing the administration of medicaments.
Career Highlights
Thomas Aaskov Pedersen is currently employed at Novo Nordisk A/S, a global leader in diabetes care and hormone replacement therapy. Through his work at Novo Nordisk, Pedersen has been instrumental in developing innovative solutions aimed at improving patient outcomes and enhancing the efficiency of medical treatments.
Collaborations
During his career, Pedersen has collaborated with other talented professionals, including his coworkers Michael Ejstrup Hansen and Søren Steenfeldt-Jensen. Together, they have worked towards pushing the boundaries of medical technology and fostering advancements that benefit patients and healthcare providers alike.
Conclusion
Thomas Aaskov Pedersen exemplifies the spirit of innovation that drives the medical field forward. His patents not only showcase his creativity and expertise but also illustrate the impact that diligent inventors can have on healthcare. As he continues to work at Novo Nordisk A/S, the medical community anticipates further groundbreaking contributions from this remarkable inventor.